Financials
Income statement
Fiscal date | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Total reported revenue | 15.3B | 16.2B | 14.4B | 12.7B |
Cost of revenue | 12.6B | 13.5B | 12.4B | 10.9B |
Gross profit | 2.7B | 2.7B | 2.0B | 1.8B |
Operating expense | ||||
Research & development | 617M | 626M | 473M | 481M |
Selling general and admin | 1B | 995M | 936M | 825M |
Other operating expenses | — | — | — | — |
Operating income | 1.0B | 1.1B | 559M | 464M |
Non operating interest income | ||||
Income | 108M | 90M | 56M | 32M |
Expense | 236M | 274M | 172M | 90M |
Other income expense | — | — | — | — |
Pretax income | 608M | 387M | 260M | 180M |
Tax provision | 70M | 153M | 101M | 104M |
Net income | 352M | 234M | 159M | 76M |
Basic EPS | 1.3 | 0.8 | 0.5 | 0.2 |
Diluted EPS | 1.3 | 0.8 | 0.5 | 0.2 |
Basic average shares | 267M | 269M | 271M | 271.2M |
Diluted average shares | 267M | 269M | 271M | 271.2M |
EBITDA | 1.6B | 1.6B | 1.0B | 907M |
Net income from continuing op. | 538M | 234M | 159M | 76M |
Minority interests | -3M | -16M | -12M | -24M |
Preferred stock dividends | 0 | 0 | 0 | 0 |